Corrigendum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

File(s)

bjc2016342a.pdf (51.41 KB)

Published version

Show more

Author(s)

Dalgleish, AG

Stebbing, J

Adamson, DJ

Arif, SS

Bidoli, P

more

Type

Journal Article

Date Issued

2016-10-11

Date Acceptance

2016-10-01

Citation

British Journal of Cancer, 2016, 115 (9), pp.e16-e16

URI

http://hdl.handle.net/10044/1/48907

DOI

https://www.dx.doi.org/10.1038/bjc.2016.342

ISSN

0007-0920

Publisher

Cancer Research UK

Start Page

e16

End Page

e16

Journal / Book Title

British Journal of Cancer

Volume

115

Issue

9

Copyright Statement

© 2016 Cancer Research UK. All rights reserved. Correction to: British Journal of Cancer (2016) 115, 789–796. doi:10.1038/bjc.2016.271. Original article at http://hdl.handle.net/10044/1/48908

Sponsor

Cancer Research UK

Identifier

http://www.ncbi.nlm.nih.gov/pubmed/27727233

PII: bjc2016342

Grant Number

14549

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

1112 Oncology And Carcinogenesis

Oncology & Carcinogenesis

Publication Status

Published

Coverage Spatial

England

Article Number

e16